10-Q Filing

OPTION CARE HEALTH, INC. CIK: 1014739 Q1 2015

Filing Information

Form Type	10-Q
Accession Number	`0001014739-15-000009`
Period End Date	20150331
Filing Date	20150508
Fiscal Year	2015
Fiscal Period	Q1
XBRL Instance	bios-20150331.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 89 Income Statement 54 Cash Flow Statement 80 Stockholders Equity 17

Balance Sheet 89 line items

Line Item	Tag	Value	Unit	Period
Allowance for Doubtful Accounts Receivable, Current	`AllowanceForDoubtfulAccountsReceivableCurrent`	$66.50M	USD	Point-in-time
Allowance for Doubtful Accounts Receivable, Current	`AllowanceForDoubtfulAccountsReceivableCurrent`	$66.84M	USD	Point-in-time
Temporary Equity, Par or Stated Value Per Share	`TemporaryEquityParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$9.25M	USD	Point-in-time
Temporary Equity, Shares Authorized	`TemporaryEquitySharesAuthorized`	825,000.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.00M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$23.25M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$740.00K	USD	Point-in-time
Receivables, less allowance for doubtful accounts of $66,836 and $66,500 as of March 31, 2015 and December 31, 2014, respectively	`ReceivablesNetCurrent`	$136.66M	USD	Point-in-time
Receivables, less allowance for doubtful accounts of $66,836 and $66,500 as of March 31, 2015 and December 31, 2014, respectively	`ReceivablesNetCurrent`	$140.81M	USD	Point-in-time
Shares issued (in shares)	`TemporaryEquitySharesIssued`	625,000.00	shares	Point-in-time
Inventory	`InventoryNet`	$41.88M	USD	Point-in-time
Inventory	`InventoryNet`	$37.22M	USD	Point-in-time
Temporary Equity, Shares Outstanding	`TemporaryEquitySharesOutstanding`	625,000.00	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$10.56M	USD	Point-in-time
Temporary Equity, Liquidation Preference	`TemporaryEquityLiquidationPreference`	$62.95M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$9.45M	USD	Point-in-time
Preferred Stock, Par or Stated Value Per Share	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total current assets	`AssetsCurrent`	$212.35M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$188.22M	USD	Point-in-time
Preferred Stock, Par or Stated Value Per Share	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$35.93M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$38.17M	USD	Point-in-time
Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	4.17M	shares	Point-in-time
Preferred Stock, Shares Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Goodwill	`Goodwill`	$573.32M	USD	Point-in-time
Preferred Stock, Shares Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Goodwill	`Goodwill`	$573.32M	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$10.27M	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$8.78M	USD	Point-in-time
Preferred Stock, Shares Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred Stock, Shares Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Common Stock, Par or Stated Value Per Share	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common Stock, Par or Stated Value Per Share	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Deferred financing costs	`DeferredFinanceCostsNoncurrentNet`	$13.79M	USD	Point-in-time
Deferred financing costs	`DeferredFinanceCostsNoncurrentNet`	$13.46M	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$1.27M	USD	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	125.00M	shares	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	125.00M	shares	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$1.25M	USD	Point-in-time
Common Stock, Shares, Issued	`CommonStockSharesIssued`	71.30M	shares	Point-in-time
Total assets	`Assets`	$845.42M	USD	Point-in-time
Common Stock, Shares, Issued	`CommonStockSharesIssued`	71.27M	shares	Point-in-time
Total assets	`Assets`	$824.71M	USD	Point-in-time
Common Stock, Shares, Outstanding	`CommonStockSharesOutstanding`	68.64M	shares	Point-in-time
Common Stock, Shares, Outstanding	`CommonStockSharesOutstanding`	68.65M	shares	Point-in-time
Treasury Stock, Shares	`TreasuryStockShares`	2.64M	shares	Point-in-time
Treasury Stock, Shares	`TreasuryStockShares`	2.65M	shares	Point-in-time
Current portion of long-term debt	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$5.39M	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$325.00K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$91.11M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$90.03M	USD	Point-in-time
Claims payable	`SupplementaryInsuranceInformationLiabilityForFuturePolicyBenefitsLossesClaimsAndLossExpenseReserves`	$5.78M	USD	Point-in-time
Claims payable	`SupplementaryInsuranceInformationLiabilityForFuturePolicyBenefitsLossesClaimsAndLossExpenseReserves`	$8.16M	USD	Point-in-time
Amounts due to plan sponsors	`AmountsDueToPlanSponsors`	$4.20M	USD	Point-in-time
Amounts due to plan sponsors	`AmountsDueToPlanSponsors`	$5.78M	USD	Point-in-time
Accrued interest	`InterestPayableCurrent`	$6.85M	USD	Point-in-time
Accrued interest	`InterestPayableCurrent`	$2.27M	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedExpensesAndOtherCurrentLiabilities`	$46.09M	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedExpensesAndOtherCurrentLiabilities`	$41.48M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$145.16M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$162.31M	USD	Point-in-time
Long-term debt, net of current portion	`LongTermDebtAndCapitalLeaseObligations`	$418.50M	USD	Point-in-time
Long-term debt, net of current portion	`LongTermDebtAndCapitalLeaseObligations`	$418.41M	USD	Point-in-time
Deferred taxes	`DeferredTaxLiabilitiesGrossNoncurrent`	$19.06M	USD	Point-in-time
Deferred taxes	`DeferredTaxLiabilitiesGrossNoncurrent`	$20.88M	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$8.13M	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$2.66M	USD	Point-in-time
Total liabilities	`Liabilities`	$607.91M	USD	Point-in-time
Total liabilities	`Liabilities`	$587.20M	USD	Point-in-time
Series A convertible preferred stock, $.0001 par value; 825,000 shares authorized; 625,000 shares issued and outstanding; and, $62,953 liquidation preference as of March 31, 2015. No preferred stock was authorized or outstanding as of December 31, 2014.	`TemporaryEquityCarryingAmountAttributableToParent`	$54.00M	USD	Point-in-time
Series A convertible preferred stock, $.0001 par value; 825,000 shares authorized; 625,000 shares issued and outstanding; and, $62,953 liquidation preference as of March 31, 2015. No preferred stock was authorized or outstanding as of December 31, 2014.	`TemporaryEquityCarryingAmountAttributableToParent`	-	USD	Point-in-time
Preferred stock, $.0001 par value; 4,175,000 and 5,000,000 shares authorized as of March 31, 2015 and December 31, 2014, respectively; no shares issued and outstanding as of March 31, 2015 and December 31, 2014, respectively	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $.0001 par value; 4,175,000 and 5,000,000 shares authorized as of March 31, 2015 and December 31, 2014, respectively; no shares issued and outstanding as of March 31, 2015 and December 31, 2014, respectively	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $.0001 par value; 125,000,000 shares authorized; 71,295,564 and 71,274,064 shares issued and 68,650,271 and 68,636,965 shares outstanding as of March 31, 2015 and December 31, 2014, respectively	`CommonStockValue`	$8.00K	USD	Point-in-time
Common stock, $.0001 par value; 125,000,000 shares authorized; 71,295,564 and 71,274,064 shares issued and 68,650,271 and 68,636,965 shares outstanding as of March 31, 2015 and December 31, 2014, respectively	`CommonStockValue`	$8.00K	USD	Point-in-time
Treasury stock, 2,645,293 and 2,637,099 shares at cost as of March 31, 2015 and December 31, 2014, respectively	`TreasuryStockValue`	$10.71M	USD	Point-in-time
Treasury stock, 2,645,293 and 2,637,099 shares at cost as of March 31, 2015 and December 31, 2014, respectively	`TreasuryStockValue`	$10.68M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$536.81M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$529.68M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-302.21M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-321.88M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$332.66M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$354.58M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$204.23M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$216.81M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$824.71M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$845.42M	USD	Point-in-time

Income Statement 54 line items

Line Item	Tag	Value	Unit	Period
Product revenue	`HealthCareOrganizationOtherRevenue`	$215.90M	USD	1 Quarter
Product revenue	`HealthCareOrganizationOtherRevenue`	$239.05M	USD	1 Quarter
Service revenue	`HealthCareOrganizationPatientServiceRevenue`	$23.39M	USD	1 Quarter
Service revenue	`HealthCareOrganizationPatientServiceRevenue`	$22.63M	USD	1 Quarter
Total revenue	`HealthCareOrganizationRevenue`	$261.68M	USD	1 Quarter
Total revenue	`HealthCareOrganizationRevenue`	$239.29M	USD	1 Quarter
Cost of product revenue	`HealthCareOrganizationMedicalSuppliesAndDrugsExpense`	$151.74M	USD	1 Quarter
Cost of product revenue	`HealthCareOrganizationMedicalSuppliesAndDrugsExpense`	$173.95M	USD	1 Quarter
Cost of service revenue	`CostOfServices`	$21.26M	USD	1 Quarter
Cost of service revenue	`CostOfServices`	$22.45M	USD	1 Quarter
Total cost of revenue	`CostOfRevenue`	$174.19M	USD	1 Quarter
Total cost of revenue	`CostOfRevenue`	$195.21M	USD	1 Quarter
Gross profit	`GrossProfit`	$65.10M	USD	1 Quarter
Gross profit	`GrossProfit`	$66.47M	USD	1 Quarter
Selling, general and administrative expenses	`OtherSellingGeneralAndAdministrativeExpense`	$59.18M	USD	1 Quarter
Selling, general and administrative expenses	`OtherSellingGeneralAndAdministrativeExpense`	$57.77M	USD	1 Quarter
Change in fair value of contingent consideration	`GainLossonChangeinFairValueofContingentConsideration`	$2.21M	USD	1 Quarter
Change in fair value of contingent consideration	`GainLossonChangeinFairValueofContingentConsideration`	$-21.00K	USD	1 Quarter
Bad debt expense	`ProvisionForDoubtfulAccounts`	$8.32M	USD	1 Quarter
Bad debt expense	`ProvisionForDoubtfulAccounts`	$6.60M	USD	1 Quarter
Acquisition and integration expenses	`AcquisitionAndIntegrationExpenses`	$6.50M	USD	1 Quarter
Acquisition and integration expenses	`AcquisitionAndIntegrationExpenses`	$220.00K	USD	1 Quarter
Restructuring and other expenses	`RestructuringCharges`	$3.46M	USD	1 Quarter
Restructuring and other expenses	`RestructuringCharges`	$4.59M	USD	1 Quarter
Amortization of intangibles	`AmortizationOfIntangibleAssets`	$1.70M	USD	1 Quarter
Amortization of intangibles	`AmortizationOfIntangibleAssets`	$1.49M	USD	1 Quarter
Loss from continuing operations	`OperatingIncomeLoss`	$-11.27M	USD	1 Quarter
Loss from continuing operations	`OperatingIncomeLoss`	$-4.81M	USD	1 Quarter
Interest expense, net	`InterestIncomeExpenseNet`	$-9.16M	USD	1 Quarter
Interest expense, net	`InterestIncomeExpenseNet`	$-10.50M	USD	1 Quarter
Loss from continuing operations before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-21.77M	USD	1 Quarter
Loss from continuing operations before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-13.98M	USD	1 Quarter
Income tax expense (benefit)	`IncomeTaxExpenseBenefit`	$3.49M	USD	1 Quarter
Income tax expense (benefit)	`IncomeTaxExpenseBenefit`	$1.93M	USD	1 Quarter
Loss from continuing operations, net of income taxes	`IncomeLossFromContinuingOperations`	$-25.26M	USD	1 Quarter
Loss from continuing operations, net of income taxes	`IncomeLossFromContinuingOperations`	$-15.90M	USD	1 Quarter
Loss from discontinued operations, net of income taxes	`IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity`	$-3.77M	USD	1 Quarter
Loss from discontinued operations, net of income taxes	`IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity`	$-58.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-25.31M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-19.67M	USD	1 Quarter
Accrued dividends on preferred stock	`TemporaryEquityDividendsAdjustment`	-	USD	1 Quarter
Accrued dividends on preferred stock	`TemporaryEquityDividendsAdjustment`	$453.00K	USD	1 Quarter
Deemed dividend on preferred stock	`TemporaryEquityAccretionToRedemptionValueAdjustment`	-	USD	1 Quarter
Deemed dividend on preferred stock	`TemporaryEquityAccretionToRedemptionValueAdjustment`	$1.16M	USD	1 Quarter
Loss attributable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-25.31M	USD	1 Quarter
Loss attributable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-21.29M	USD	1 Quarter
Loss from continuing operations, basic and diluted (in dollars per share)	`IncomeLossFromContinuingOperationsPerBasicAndDilutedShare`	$-0.26	USD	1 Quarter
Loss from continuing operations, basic and diluted (in dollars per share)	`IncomeLossFromContinuingOperationsPerBasicAndDilutedShare`	$-0.37	USD	1 Quarter
Loss from discontinued operations, basic and diluted (in dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare`	-	USD	1 Quarter
Loss from discontinued operations, basic and diluted (in dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare`	$-0.05	USD	1 Quarter
Loss per common share, basic and diluted (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.37	USD	1 Quarter
Loss per common share, basic and diluted (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.31	USD	1 Quarter
Weighted average number of common shares outstanding (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	68.64M	shares	1 Quarter
Weighted average number of common shares outstanding (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	68.17M	shares	1 Quarter

Cash Flow Statement 80 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-25.31M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-19.67M	USD	1 Quarter
Less: loss from discontinued operations, net of income taxes	`IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity`	$-3.77M	USD	1 Quarter
Less: loss from discontinued operations, net of income taxes	`IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity`	$-58.00K	USD	1 Quarter
Loss from continuing operations, net of income taxes	`IncomeLossFromContinuingOperations`	$-25.26M	USD	1 Quarter
Loss from continuing operations, net of income taxes	`IncomeLossFromContinuingOperations`	$-15.90M	USD	1 Quarter
Depreciation	`Depreciation`	$4.30M	USD	1 Quarter
Depreciation	`Depreciation`	$3.84M	USD	1 Quarter
Amortization of intangibles	`AmortizationOfIntangibleAssets`	$1.70M	USD	1 Quarter
Amortization of intangibles	`AmortizationOfIntangibleAssets`	$1.49M	USD	1 Quarter
Amortization of deferred financing costs and debt discount	`AmortizationOfFinancingCostsAndDiscounts`	$780.00K	USD	1 Quarter
Amortization of deferred financing costs and debt discount	`AmortizationOfFinancingCostsAndDiscounts`	$1.94M	USD	1 Quarter
Change in fair value of contingent consideration	`IncreaseDecreaseinFairValueofContingentConsideration`	$2.21M	USD	1 Quarter
Change in fair value of contingent consideration	`IncreaseDecreaseinFairValueofContingentConsideration`	$-21.00K	USD	1 Quarter
Change in deferred income taxes	`IncreaseDecreaseInDeferredIncomeTaxes`	$-1.93M	USD	1 Quarter
Change in deferred income taxes	`IncreaseDecreaseInDeferredIncomeTaxes`	$-2.71M	USD	1 Quarter
Compensation under stock-based compensation plans	`ShareBasedCompensation`	$2.89M	USD	1 Quarter
Compensation under stock-based compensation plans	`ShareBasedCompensation`	$1.66M	USD	1 Quarter
Receivables, net of bad debt expense	`IncreaseDecreaseInReceivables`	$-4.15M	USD	1 Quarter
Receivables, net of bad debt expense	`IncreaseDecreaseInReceivables`	$22.90M	USD	1 Quarter
Inventory	`IncreaseDecreaseInInventories`	$413.00K	USD	1 Quarter
Inventory	`IncreaseDecreaseInInventories`	$4.67M	USD	1 Quarter
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$838.00K	USD	1 Quarter
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-1.48M	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayableTrade`	$4.64M	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayableTrade`	$1.08M	USD	1 Quarter
Claims payable	`IncreaseDecreaseInFuturePolicyBenefitReserves`	$5.37M	USD	1 Quarter
Claims payable	`IncreaseDecreaseInFuturePolicyBenefitReserves`	$-2.39M	USD	1 Quarter
Amounts due to plan sponsors	`IncreaseDecreaseinAmountsDueToPlanSponsor`	$-1.57M	USD	1 Quarter
Amounts due to plan sponsors	`IncreaseDecreaseinAmountsDueToPlanSponsor`	$1.14M	USD	1 Quarter
Accrued interest	`IncreaseDecreaseInInterestPayableNet`	$-4.58M	USD	1 Quarter
Accrued interest	`IncreaseDecreaseInInterestPayableNet`	$134.00K	USD	1 Quarter
Accrued expenses and other liabilities	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$-9.73M	USD	1 Quarter
Accrued expenses and other liabilities	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$634.00K	USD	1 Quarter
Net cash (used in) operating activities from continuing operations	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-24.28M	USD	1 Quarter
Net cash (used in) operating activities from continuing operations	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-24.32M	USD	1 Quarter
Net cash (used in) operating activities from discontinued operations	`CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations`	$-3.77M	USD	1 Quarter
Net cash (used in) operating activities from discontinued operations	`CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations`	$-1.67M	USD	1 Quarter
Net cash (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-28.05M	USD	1 Quarter
Net cash (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-25.99M	USD	1 Quarter
Purchases of property and equipment, net	`PaymentsForProceedsFromProductiveAssets`	$3.06M	USD	1 Quarter
Purchases of property and equipment, net	`PaymentsForProceedsFromProductiveAssets`	$2.07M	USD	1 Quarter
Net cash (used in) investing activities from continuing operations	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-2.07M	USD	1 Quarter
Net cash (used in) investing activities from continuing operations	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-3.06M	USD	1 Quarter
Net cash provided by investing activities from discontinued operations	`CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations`	$56.62M	USD	1 Quarter
Net cash provided by investing activities from discontinued operations	`CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations`	-	USD	1 Quarter
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$53.56M	USD	1 Quarter
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-2.07M	USD	1 Quarter
Proceeds from issuance of convertible preferred stock and warrants, net of issuance costs	`ProceedsfromIssuanceofConvertiblePreferredStockandWarrants`	$58.95M	USD	1 Quarter
Proceeds from issuance of convertible preferred stock and warrants, net of issuance costs	`ProceedsfromIssuanceofConvertiblePreferredStockandWarrants`	-	USD	1 Quarter
Proceeds from senior notes due 2021, net of fees paid to lenders	`ProceedsFromIssuanceOfSeniorLongTermDebt`	-	USD	1 Quarter
Proceeds from senior notes due 2021, net of fees paid to lenders	`ProceedsFromIssuanceOfSeniorLongTermDebt`	$193.81M	USD	1 Quarter
Deferred and other financing costs	`PaymentsOfFinancingCosts`	$1.21M	USD	1 Quarter
Deferred and other financing costs	`PaymentsOfFinancingCosts`	$1.22M	USD	1 Quarter
Borrowings on line of credit	`ProceedsFromLongTermLinesOfCredit`	$64.60M	USD	1 Quarter
Borrowings on line of credit	`ProceedsFromLongTermLinesOfCredit`	$74.96M	USD	1 Quarter
Repayments on line of credit	`RepaymentsOfLongTermLinesOfCredit`	$79.96M	USD	1 Quarter
Repayments on line of credit	`RepaymentsOfLongTermLinesOfCredit`	$104.60M	USD	1 Quarter
Principal payments on long-term debt	`ProceedsFromRepaymentsOfSecuredDebt`	-	USD	1 Quarter
Principal payments on long-term debt	`ProceedsFromRepaymentsOfSecuredDebt`	$-172.24M	USD	1 Quarter
Repayments of capital leases	`RepaymentsOfLongTermCapitalLeaseObligations`	$98.00K	USD	1 Quarter
Repayments of capital leases	`RepaymentsOfLongTermCapitalLeaseObligations`	$114.00K	USD	1 Quarter
Net proceeds from exercise of employee stock compensation plans	`ProceedsFromStockOptionsExercised`	$427.00K	USD	1 Quarter
Net proceeds from exercise of employee stock compensation plans	`ProceedsFromStockOptionsExercised`	-	USD	1 Quarter
Net cash provided by (used in) financing activities from continuing operations	`NetCashProvidedByUsedInFinancingActivities`	$-19.32M	USD	1 Quarter
Net cash provided by (used in) financing activities from continuing operations	`NetCashProvidedByUsedInFinancingActivities`	$52.62M	USD	1 Quarter
Net change in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$22.51M	USD	1 Quarter
Net change in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$8.25M	USD	1 Quarter
Cash and cash equivalents - beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$9.25M	USD	Point-in-time
Cash and cash equivalents - beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$1.00M	USD	Point-in-time
Cash and cash equivalents - beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$23.25M	USD	Point-in-time
Cash and cash equivalents - beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$740.00K	USD	Point-in-time
Cash and cash equivalents - end of period	`CashAndCashEquivalentsAtCarryingValue`	$9.25M	USD	Point-in-time
Cash and cash equivalents - end of period	`CashAndCashEquivalentsAtCarryingValue`	$1.00M	USD	Point-in-time
Cash and cash equivalents - end of period	`CashAndCashEquivalentsAtCarryingValue`	$23.25M	USD	Point-in-time
Cash and cash equivalents - end of period	`CashAndCashEquivalentsAtCarryingValue`	$740.00K	USD	Point-in-time
Cash paid during the period for interest	`InterestPaidNet`	$13.75M	USD	1 Quarter
Cash paid during the period for interest	`InterestPaidNet`	$8.48M	USD	1 Quarter
Cash paid during the period for income taxes	`IncomeTaxesPaidNet`	$528.00K	USD	1 Quarter
Cash paid during the period for income taxes	`IncomeTaxesPaidNet`	$-314.00K	USD	1 Quarter

Stockholders Equity 17 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquity`	$332.66M	USD	Point-in-time
Balance	`StockholdersEquity`	$354.58M	USD	Point-in-time
Balance	`StockholdersEquity`	$204.23M	USD	Point-in-time
Balance	`StockholdersEquity`	$216.81M	USD	Point-in-time
Issuance of Series A convertible preferred stock and warrants	`AdjustmentstoAdditionalPaidinCapitalPrivateInvestmentinPublicEquityTransaction`	$6.57M	USD	1 Quarter
Accrued dividends on preferred stock	`AdjustmentstoAdditionalPaidinCapitalIncreaseinLiquidationPreferenceonTemporaryEquity`	$453.00K	USD	1 Quarter
Deemed dividend on preferred stock	`AdjustmentstoAdditionalPaidinCapitalAccretionofDiscountonTemporaryEquity`	$1.16M	USD	1 Quarter
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$428.00K	USD	1 Quarter
Compensation under employee stock compensation plan	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$2.96M	USD	1 Quarter
Compensation under employee stock compensation plan	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$2.18M	USD	1 Quarter
Surrender of stock to satisfy minimum tax withholding	`AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation`	$36.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-25.31M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-19.67M	USD	1 Quarter
Balance	`StockholdersEquity`	$332.66M	USD	Point-in-time
Balance	`StockholdersEquity`	$354.58M	USD	Point-in-time
Balance	`StockholdersEquity`	$204.23M	USD	Point-in-time
Balance	`StockholdersEquity`	$216.81M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.